CClinicalTrials.gg
CompletedNCT03610087TECC-YUpdated Jul 15, 2020

Technology-Enabled Collaborative Care for Youth

An interventional study of Low Intensity Intervention and High Intensity Intervention in Psychosis, Metabolic Disease and Cardiovascular Risk Factor, sponsored by Centre for Addiction and Mental Health. Completed at 1 site in Canada. Open to participants aged 16 Years to 29 Years. Per ClinicalTrials.gov, last updated 2020-07-15.

Sponsored by Centre for Addiction and Mental Health · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
16 Years to 29 Years
Sex
All
01

Study summary

The overall objective is to develop scalable interventions to address the physical health needs of patients affected by early psychosis. The objective of this project is to conduct a feasibility study of a high intensity technology-enabled collaborative care model (CCM) compared to lower intensity self-help modules and email support for early identification and treatment of cardio-metabolic risk factors in youth, ages 16-29, affected by early psychosis.

02

Conditions studied

  • Psychosis
  • Metabolic Disease
  • Cardiovascular Risk Factor

Browse trials for

03

In context

Metabolic Diseases

997 studies on the registry are indexed under Metabolic Diseases; 234 are open to participants now.

This study's enrollment of 70 is above the median of 48 across 670 interventional studies indexed under Metabolic Diseases.

Browse Metabolic Diseases studies →

Lead sponsor

Centre for Addiction and Mental Health is the lead sponsor of 327 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 29 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Ages 16 - 29 years
  • Clinician diagnosis of early psychosis (diagnosed in last 5 years)
  • Prescribed psychiatric medication, stable for 4 weeks
  • Access to telephone or internet through computer or mobile

Exclusion criteria

Exclusion Criteria:

  • Unable to provide consent
  • Unable to understand English
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
70 participants (actual)

Study arms

  • Other
    Low Intensity Intervention

    The comparison group (low intensity) receives access to the e-platform and given an educational package with information about nutrition, physical activity, and smoking based on the NAVIGATE program (Mueser et al., 2015); i.e., a comprehensive program for implementing coordinated speciality care) with weekly e-mail reminders for 12 weeks. Participants receive access to online resources and free online webinars about these healthy behaviours.

    Behavioral: Low Intensity Intervention

  • Experimental
    High Intensity Intervention

    The intervention group (high intensity) receives a technology-enabled CCM intervention. Participants receive access to an online platform and infographic modules to learn more about nutrition, physical activity, and smoking cessation. Also, they are assigned a personal health coach who collaboratively schedules weekly virtual sessions via the platform to discuss the educational materials, goal setting and motivation, and provide support in the 12-week program. The participant's health coach reviews the participant's concerns and goals weekly with a virtual care team (VCT; including a psychiatrist, addictions specialist, nutrition specialist, peer mentor, and recreational therapist), who provides individualized recommendations to include in the participant's treatment plan. Participants have access to online resources and online webinars about nutrition, physical activity and smoking.

    Behavioral: High Intensity Intervention

Interventions

  • BehavioralLow Intensity Intervention

    Participants will have access via the online platform to the NAVIGATE self-help modules for physical activity, nutrition and quitting smoking with a list of community resources. Subjects will be sent a standard reminder emails once per week to complete their modules and connect with their main provider for any assistance.

  • BehavioralHigh Intensity Intervention

    Participants will receive individualized treatment planning, in collaboration with a Care Coordinator, and the Virtual Care Team (VCT). Interactive modules on physical activity, nutrition and quitting smoking will be provided via the online platform. the virtual team will be engaged to provide treatment and/or recommendations regarding the following: increasing physical activity, improving nutrition and diet, smoking cessation (psychosocial support plus medications), and medication adherence. Participants in this arm will have weekly check-ins with their assigned Care Coordinator where they will be able to discuss VCT recommendations, and progress on their goals.

    Also known as: TECC-Y

06

What researchers measure

Primary outcomes

  1. Change in patient engagement

    The primary outcome is patient engagement will be defined as participant activation in the program measured via self-report levels of perceived benefit from the program.

    Time frame: Baseline, 6-weeks, 12-weeks, and 24-weeks.

Secondary outcomes

  1. Healthy Behaviour Change

    The secondary outcome is to explore whether a CCM will help facilitate healthy behavioral changes in physical activity, nutrition, and smoking.

    Time frame: Baseline, 6-weeks, 12-weeks, and 24-weeks.

07

Study locations

1 site
  • Centre for Addiction and Mental Health
    Toronto, Ontario M5T1P7, Canada
08

References and documents

Publications

  • Selby P, Vojtila L, Ashfaq I, Dragonetti R, Melamed OC, Carriere R, LaChance L, Kohut SA, Hahn M, Mulsant BH. Technology-enabled collaborative care for youth with early psychosis: A protocol for a feasibility study to improve physical health behaviours. Early Interv Psychiatry. 2021 Aug;15(4):828-836. doi: 10.1111/eip.13018. Epub 2020 Aug 3. PubMed 32748501 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03610087
Lead sponsor
Centre for Addiction and Mental Health
Collaborators
Medical Psychiatry Alliance, Trillium Health Centre, The Hospital for Sick Children, University of Toronto
Responsible party
Peter Selby (Deputy Physician-in-Chief- Education|Clinician Scientist|Chief, Medicine in Psychiatry Division|CAMH|, Centre for Addiction and Mental Health) — Principal investigator
First posted
Aug 1, 2018
Start date
Jul 25, 2018
Primary completion
Jun 30, 2020
Completion
Jun 30, 2020
Last update
Jul 15, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion